Mol Autism:孕期使用叶酸补充剂与儿童孤独症谱系障碍风险之间的关系

2019-09-16 不详 网络

既往研究评估了孕期使用叶酸补充剂与儿童孤独症谱系障碍(ASD)风险之间的关系,但没有明确的结论。因此,我们进行了更全面的荟萃分析,以重新评估叶酸与ASD风险之间的关系。研究检索了PubMed,Web of Knowledge和Wanfang Data电子数据库进行了仔细搜索,纳入2017年3月新近发表的符合条件的研究。使用随机效应模型将相对风险(RR)与95%置信区间(CI)相结合。进行了敏感性分

既往研究评估了孕期使用叶酸补充剂与儿童孤独症谱系障碍(ASD)风险之间的关系,但没有明确的结论。因此,我们进行了更全面的荟萃分析,以重新评估叶酸与ASD风险之间的关系。

研究检索了PubMed,Web of Knowledge和Wanfang Data电子数据库进行了仔细搜索,纳入2017年3月新近发表的符合条件的研究。使用随机效应模型将相对风险(RR)与95%置信区间(CI)相结合。进行了敏感性分析,并评估发表文章的偏倚。

本报告共纳入12篇文章,包括16项研究,4514例ASD病例。结果发现,与没有补充叶酸的女性相比,怀孕期间补充叶酸可降低ASD的风险[RR = 0.771,95%CI = 0.641-0.928,I2 = 59.7%,异质性= 0.001]。这些关联在亚洲,欧洲和美国人群中具有重要意义。

总之,这项全面的荟萃分析表明,与不补充叶酸的女性相比,孕期使用叶酸补充剂可以显著降低儿童ASD的风险,而无论其种族如何。

原始出处:

Wang M, Li K, et al., The association between maternal use of folic acid supplements during pregnancy and risk of autism spectrum disorders in children: a meta-analysis. Mol Autism. 2017 Oct 2;8:51. doi: 10.1186/s13229-017-0170-8. eCollection 2017.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2071316, encodeId=1ddd20e131610, content=<a href='/topic/show?id=b5d2300622' target=_blank style='color:#2F92EE;'>#autism#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3006, encryptionId=b5d2300622, topicName=autism)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Fri Feb 07 21:45:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634728, encodeId=a5cd1634e2802, content=<a href='/topic/show?id=752938e10b2' target=_blank style='color:#2F92EE;'>#叶酸补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38710, encryptionId=752938e10b2, topicName=叶酸补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091122265773, createdName=Tamikia, createdTime=Sun Aug 23 03:45:00 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619158, encodeId=1c5b1619158dc, content=<a href='/topic/show?id=474f45446bc' target=_blank style='color:#2F92EE;'>#孤独症谱系障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45446, encryptionId=474f45446bc, topicName=孤独症谱系障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Sep 18 09:45:00 CST 2019, time=2019-09-18, status=1, ipAttribution=)]
    2020-02-07 xuyu
  2. [GetPortalCommentsPageByObjectIdResponse(id=2071316, encodeId=1ddd20e131610, content=<a href='/topic/show?id=b5d2300622' target=_blank style='color:#2F92EE;'>#autism#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3006, encryptionId=b5d2300622, topicName=autism)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Fri Feb 07 21:45:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634728, encodeId=a5cd1634e2802, content=<a href='/topic/show?id=752938e10b2' target=_blank style='color:#2F92EE;'>#叶酸补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38710, encryptionId=752938e10b2, topicName=叶酸补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091122265773, createdName=Tamikia, createdTime=Sun Aug 23 03:45:00 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619158, encodeId=1c5b1619158dc, content=<a href='/topic/show?id=474f45446bc' target=_blank style='color:#2F92EE;'>#孤独症谱系障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45446, encryptionId=474f45446bc, topicName=孤独症谱系障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Sep 18 09:45:00 CST 2019, time=2019-09-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2071316, encodeId=1ddd20e131610, content=<a href='/topic/show?id=b5d2300622' target=_blank style='color:#2F92EE;'>#autism#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3006, encryptionId=b5d2300622, topicName=autism)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Fri Feb 07 21:45:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634728, encodeId=a5cd1634e2802, content=<a href='/topic/show?id=752938e10b2' target=_blank style='color:#2F92EE;'>#叶酸补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38710, encryptionId=752938e10b2, topicName=叶酸补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091122265773, createdName=Tamikia, createdTime=Sun Aug 23 03:45:00 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619158, encodeId=1c5b1619158dc, content=<a href='/topic/show?id=474f45446bc' target=_blank style='color:#2F92EE;'>#孤独症谱系障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45446, encryptionId=474f45446bc, topicName=孤独症谱系障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Sep 18 09:45:00 CST 2019, time=2019-09-18, status=1, ipAttribution=)]